Japan's insulin pen market sees 3% CAGR growth

The country comprised a 28% market share of insulin pens in the Asia-Pacific.

The insulin pen market in Japan is on the rise, with a projected 3% compound annual growth rate until 2033, according to GlobalData.

The report also said the country's healthcare sector is seeing a rise in insulin pen usage, valued for their precision and ease of use, as a response to the diabetes challenge.

This growth, however, comes with environmental concerns as these pens contribute to biomedical waste. 

"Patients opt for insulin pens not only for their convenience but also for their ability to minimize biomedical waste, necessitating specialised disposal methods,” said Aditi Dakshesh Parikh, Medical Devices Analyst at GlobalData. “However, the environmental repercussions of discarding single-use injection pens in Japan raise significant concerns.”

She pointed out the importance of going beyond waste management to promote environmental sustainability in healthcare. 

Parikh noted that implementing effective strategies to minimise the environmental impact of disposal methods is crucial for preserving resources and ensuring a healthier and sustainable future.

In addition to concerns regarding biomedical waste, approximately 77% of insulin pens in Japan are made of plastic, further exacerbating environmental issues. Disposal of these pens is often managed by municipal governments or healthcare facilities through methods such as landfilling or cremation.

ALSO READ: Surgical devices market to exceed $20b in 2033

Japan accounted for a 28% market share of insulin pens in the Asia-Pacific region in 2023, as per the Insulin Pens Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 report.

"The intersection of healthcare needs, environmental concerns, and technological advancements highlights the importance of adopting sustainable practices in diabetes management,” said Parikh.